This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Collagen And HA-Based Biomaterials Industry

2. MARKET TRENDS AND ISSUES II-8Increasing Preference for Shorter and Convenient TreatmentOptions II-8Manufacturers Target Private Healthcare Market II-8Population/Baby Boomers Play a Major Role II-8Injectables Market on a High Growth Curve II-8Skin Care Products Continue to Dominate Cosmeceuticals II-9Hyaluronic-Acid Based Products Replace Other Facial ImplantProducts II-9Biomaterial Research Develops New Applications II-9Issues and Threats II-10Potential Shortage of Biomaterials II-10Inadequate Reimbursements II-10

3. BIOMATERIALS - A BRIEF OVERVIEW II-11Definition II-11Types of Biomaterials for Medical Devices II-11Polymers II-11Composites II-11Metals & Alloys II-11Ceramics II-12Biological Biomaterials II-12Application of Various Forms of Biomaterials II-12Collagen & Ha-Based Biomaterials II-12Collagen Based Biomaterials II-13What is Collagen? II-13Collagen-Based Biomaterials II-13Various Forms of Collagen and Applications II-14Soft Tissue Fillers Offer Patients More Options II-14Threatened by Alternatives II-14Hyaluronic Acid (HA) II-14Table 3: HA Distribution in the Body (includes correspondingGraph/Chart) II-15Properties of HA II-15

4. SEGMENT OVERVIEW II-16Collagen Based Products II-16Urinary Incontinence Implants II-16Classification of Urinary Incontinence II-16Stress Incontinence II-16Urge Incontinence II-16Overflow Incontinence II-16Functional Incontinence II-17Treatment of Urinary Incontinence II-17Periurethral injections (Collagen Injections) II-17Collagen Corneal Shields II-17Research Proceedings II-18Application of Collagen Shields II-18Ocular Surface Lubrication II-18Ocular Surface Protection II-18Drug Delivery II-18Wound Healing II-18Facial Aesthetic Dermal fillers II-18Functions of Collagen-based Facial Implants II-19Aesthetic Dermal fillers - Playing a Major Role II-19Normal Skin Changes Associated with Aging II-19Collagen Injections as Facial implants II-19Wound Dressings II-19Leading Players in the Collagen-based Wound Dressings Market II-20Global Wound Care Market Flaunts Steady Growth II-20Other Applications of Collagen II-21Collagen Gene Delivery Systems II-21Collagen as Bone Graft Substitution II-21Artificial Skin II-21Hyaluronic Acid Based Biomaterials II-21Viscosupplementation II-22Hyaluronic Acid as Viscosupplement II-22Viscosupplementation Treatment for Osteoarthritis II-22Major Hyaluronic Acid Based Viscosupplements II-22Viscoelastics II-23Facial Aesthetic Dermal fillers II-23Commercially Available HA Soft Tissue Fillers II-23Review of Select HA based Aesthetic Dermal Implant Products II-23Advantages of HA Based Products Over Collagen Products II-24Vesicoureteral Reflux Implants II-24Botox - A Competing Biomaterial II-24

5. PRODUCT INTRODUCTIONS/INNOVATIONS II-25Innocoll Completes Phase 2 Studies of XaraColl® II-25Abbott Receives European CE Mark for Healon® EndoCoat OVD II-25Innocoll Obtains EU Approval of CollaGUARD Surgical AdhesionBarrier II-25LSP Bio Introduces SportVis™ and RenehaVis™ II-26Lupin launches Hyalgan in India II-26TiGenix Unveils ChondroMimetic™ II-26TiGenix Develops Collagen Biomaterial for Regenerative Repair II-26Lincoln Pharma Introduces Collagen Bio-Tech Products II-27Healthpoint Launches SANTYL® Ointment for Canadian Market II-27Teijin Pharma Introduces SYNVISC in Japan II-27MiMedx Group Introduces New Paradis Vaso Shield™ Device II-28Lifecore Introduces Corgel™ Biohydrogel II-28

6. RECENT INDUSTRY ACTIVITY II-29Royal DSM Takes Over Kensey Nash II-29Angel Biotechnology Holdings Acquires Specific Assets ofCollagen and Biomaterial Manufacturing Business II-29Innocoll Signs License and Distribution Agreement with InresaArzneimittel and Flynn Pharma II-30ConvaTec Acquires Trio Healthcare International II-30ConvaTec Holdings UK Acquires SureCalm Healthcare Holdings II-30Mölnlycke Health Care US Takes Over Burn and Wound CareDivision of Brennen Medical II-31Systagenix Takes Over O2 Insights II-31Smith & Nephew Takes Over Kalypto Medical II-32Novozymes Starts Supply of Hyaluronic Acid II-32Galderma Acquires Q-Med II-32Fidia Obtains Commercial Rights of Hyalgan from Sanofi US II-33Anika Therapeutics and DePuy Mitek Ink licensing and supplyAgreement II-33Merz Pharmaceutical Acquires BioForm Medical II-33Landec Corporation Takes Over Lifecore Biomedical II-33Anika Therapeutics Takes Over Fidia Advanced Biopolymers II-34Anika Inks Agreement with Visco Technologies II-35Kinetic Concepts Signs Agreement with Wright Medical Group II-35Healthpoint Biotherapeutics Takes Over Regranex Gel II-35Innocoll and Merus Labs Sign License and DistributionAgreement for CollaGUARD II-36SCA Acquires Majority Interest in San Saglik II-36Sanofi Completes Genzyme Buyout II-36Derma Sciences Inks Exclusive Distribution Agreement withMedline Industries II-36Quick- Med Technologies Signs Deal with Biosara Corp II-37Medline Industries Enters into Wound Dressing DistributionAgreement with Quick-Med Licensee II-37BSX Signs Marketing Agreement with BHN II-37Medtronic Acquires Osteotech II-38Landec Completes Acquisition of Lifecore Biomedical II-38Merz Completes Take Overof BioForm Medical II-38

2 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.38 0.38%
FB $99.90 -4.00%
GOOG $672.98 -1.50%
TSLA $150.16 -7.70%
YHOO $26.68 -4.60%


Chart of I:DJI
DOW 15,892.89 -312.08 -1.93%
S&P 500 1,846.54 -33.51 -1.78%
NASDAQ 4,271.0420 -92.1020 -2.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs